Cellectis — Regulatory Filings 2022

Jul 5, 2022

CORRESP 1 filename1.htm CORRESP

Cellectis S.A.

8, rue de la Croix Jarry

75013 Paris, France

July 5, 2022

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Mr. Gary Guttenberg

RE: Cellectis S.A.

Registration Statement on Form F-3 (File No. 333-265826)

Ladies and Gentlemen:

In accordance with Rules 460 and 461 under the Securities Act of 1933, as amended, Cellectis S.A. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form F-3 to become effective on July 7, 2022 at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant also hereby requests a copy of the written order verifying the effective date.

Please contact Peter Devlin of Jones Day at (212) 326-3978 if you have any questions concerning the foregoing. Thank you for your attention to this matter.

Very truly yours,
CELLECTIS S.A.
By:	/s/ André Choulika
André Choulika
Chief Executive Officer

cc: Peter Devlin, Jones Day